Xylyx Bio Announces Development of Disease-Specific Cell Culture Products to Accelerate Anti-Fibrotic Drug Discovery and Screening
Fibrosis-specific substrates provide a disease-relevant in-vitro testing platform to inform decision-making in early-stage drug discovery